Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia - 23/11/17

F. Aberer ^a, 1

  Contributed equally.

, S. Kremser ^b, 1

  Contributed equally.

, J.K. Mader ^a, W. Zinke-Cerwenka ^b, H. Greinix ^b, N.J. Tripolt ^a, T.R. Pieber ^{a, d}, A. Zebisch ^b, H. Sill ^b, A. Oulhaj ^c, H. Sourij ^{a, d, ⁎} , A. Wölfler ^{b, d}

^a Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria 

^b Division of Hematology, Medical University of Graz, Graz, Austria 

^c CMHS, Institute of Public Health, United Arab Emirates University, United Arab Emirates 

^d Center for Biomarker Research in Medicine (CBmed), Graz, Austria 

^⁎Corresponding author. Division of Endocrinology and Diabetology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz. Tel.: +43 316 385 12383; fax: +43 316 385 14332.

Il testo completo di questo articolo è disponibile in PDF.